Pharmaceutical companies related to the artemisinin surged, after Chinese scientist and Nobel laureate Tu Youyou said her team has made a breakthrough in solving the problem of artemisinin resistance to treat malaria. The discovery of artemisinin, a chemical compound in a traditional Chinese herb, has saved tens of millions of lives in Africa from malaria, a deadly mosquito-borne infectious disease. Harbin Gloria Pharmaceuticals jumped by the daily 10% limit, and so did Zhuhai Rundu Pharmaceutical. Two other firms surged by 10%, while a gauge tracking 11 related stocks rose 5.6%.
Rare earth stocks rose again, after a spokesman from the National Development and Reform Commission - China's top economic planning agency - said that China is firmly opposed to the use of rare earth products to contain its development, when asked if China will use the metal as a countermeasure against the US. Rising Nonferrous Metals Share rose 5.6% to 46.7 yuan, and China Minmetals Rare Earth added 1.4% to 18.27 yuan.
CURRENCY NEWS: China yuan was little changed against greenback on Monday, as the central bank kept its morning guidance rate largely steady. Prior to the market opening on Monday, the People's Bank of China (PBOC) set the midpoint rate at 6.8940 per dollar, 3 pips weaker than the previous fix of 6.8937.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
